230 related articles for article (PubMed ID: 22538119)
1. Percutaneous cryoablation of metastatic renal cell carcinoma for local tumor control: feasibility, outcomes, and estimated cost-effectiveness for palliation.
Bang HJ; Littrup PJ; Goodrich DJ; Currier BP; Aoun HD; Heilbrun LK; Vaishampayan U; Adam B; Goodman AC
J Vasc Interv Radiol; 2012 Jun; 23(6):770-7. PubMed ID: 22538119
[TBL] [Abstract][Full Text] [Related]
2. Percutaneous cryoablation of metastatic lesions from non-small-cell lung carcinoma: initial survival, local control, and cost observations.
Bang HJ; Littrup PJ; Currier BP; Goodrich DJ; Aoun HD; Klein LC; Kuo JC; Heilbrun LK; Gadgeel S; Goodman AC
J Vasc Interv Radiol; 2012 Jun; 23(6):761-9. PubMed ID: 22626267
[TBL] [Abstract][Full Text] [Related]
3. Cost analysis of cryotherapy for metastatic disease.
Ray CE
J Vasc Interv Radiol; 2012 Jun; 23(6):778-9. PubMed ID: 22626268
[No Abstract] [Full Text] [Related]
4. Percutaneous Cryoablation of Metastatic Lesions from Colorectal Cancer: Efficacy and Feasibility with Survival and Cost-Effectiveness Observations.
Bang HJ; Littrup PJ; Currier BP; Goodrich DJ; Choi M; Heilbrun LK; Goodman AC
ISRN Minim Invasive Surg; 2012; 2012():. PubMed ID: 25621178
[TBL] [Abstract][Full Text] [Related]
5. Percutaneous cryoablation of stage T1b renal cell carcinoma: technique considerations, safety, and local tumor control.
Atwell TD; Vlaminck JJ; Boorjian SA; Kurup AN; Callstrom MR; Weisbrod AJ; Lohse CM; Hartman WR; Stockland AH; Leibovich BC; Schmit GD; Thompson RH
J Vasc Interv Radiol; 2015 Jun; 26(6):792-9. PubMed ID: 25824313
[TBL] [Abstract][Full Text] [Related]
6. Percutaneous Cryoablation of Clinical T2 (> 7 cm) Renal Masses: Technical Considerations, Complications, and Short-Term Outcomes.
Moynagh MR; Schmit GD; Thompson RH; Boorjian SA; Woodrum DA; Curry TB; Atwell TD
J Vasc Interv Radiol; 2015 Jun; 26(6):800-6. PubMed ID: 25840835
[TBL] [Abstract][Full Text] [Related]
7. Oncologic Outcomes Following Partial Nephrectomy and Percutaneous Ablation for cT1 Renal Masses.
Andrews JR; Atwell T; Schmit G; Lohse CM; Kurup AN; Weisbrod A; Callstrom MR; Cheville JC; Boorjian SA; Leibovich BC; Thompson RH
Eur Urol; 2019 Aug; 76(2):244-251. PubMed ID: 31060824
[TBL] [Abstract][Full Text] [Related]
8. Image-guided Cryoablation for Sporadic Renal Cell Carcinoma: Three- and 5-year Outcomes in 220 Patients with Biopsy-proven Renal Cell Carcinoma.
Breen DJ; King AJ; Patel N; Lockyer R; Hayes M
Radiology; 2018 Nov; 289(2):554-561. PubMed ID: 30084744
[TBL] [Abstract][Full Text] [Related]
9. Comparison of partial nephrectomy and percutaneous ablation for cT1 renal masses.
Thompson RH; Atwell T; Schmit G; Lohse CM; Kurup AN; Weisbrod A; Psutka SP; Stewart SB; Callstrom MR; Cheville JC; Boorjian SA; Leibovich BC
Eur Urol; 2015 Feb; 67(2):252-9. PubMed ID: 25108580
[TBL] [Abstract][Full Text] [Related]
10. Salvage Percutaneous Cryoablation for Locally Recurrent Renal-Cell Carcinoma After Primary Cryoablation.
Okhunov Z; Chamberlin J; Moreira DM; George A; Babaian K; Shah P; Youssef R; Kaler KS; Lobko II; Kavoussi L; Landman J
J Endourol; 2016 Jun; 30(6):632-7. PubMed ID: 27009377
[TBL] [Abstract][Full Text] [Related]
11. Outcomes of Renal Tumors Treated by Image-Guided Percutaneous Cryoablation: Immediate and 3- and 5-Year Outcomes at a Regional Center.
Lim E; Kumar S; Seager M; Modi S; Mandal I; Neves JB; Jones S; Tran MGB; Munneke G; Bandula S; Walkden M
AJR Am J Roentgenol; 2020 Jul; 215(1):242-247. PubMed ID: 32286877
[No Abstract] [Full Text] [Related]
12. Laparoscopic renal cryoablation using ultrathin 17-gauge cryoprobes: mid-term oncological and functional results.
Beemster PW; Barwari K; Mamoulakis C; Wijkstra H; de la Rosette JJ; Laguna MP
BJU Int; 2011 Aug; 108(4):577-82. PubMed ID: 21044249
[TBL] [Abstract][Full Text] [Related]
13. Cryoablation of Bone Metastases from Renal Cell Carcinoma for Local Tumor Control.
Gardner CS; Ensor JE; Ahrar K; Huang SY; Sabir SH; Tannir NM; Lewis VO; Tam AL
J Bone Joint Surg Am; 2017 Nov; 99(22):1916-1926. PubMed ID: 29135665
[TBL] [Abstract][Full Text] [Related]
14. Percutaneous Cryoablation for the Treatment of Primary and Metastatic Lung Tumors: Identification of Risk Factors for Recurrence and Major Complications.
McDevitt JL; Mouli SK; Nemcek AA; Lewandowski RJ; Salem R; Sato KT
J Vasc Interv Radiol; 2016 Sep; 27(9):1371-1379. PubMed ID: 27321886
[TBL] [Abstract][Full Text] [Related]
15. Radiofrequency Ablation, Cryoablation, and Microwave Ablation for T1a Renal Cell Carcinoma: A Comparative Evaluation of Therapeutic and Renal Function Outcomes.
Zhou W; Herwald SE; McCarthy C; Uppot RN; Arellano RS
J Vasc Interv Radiol; 2019 Jul; 30(7):1035-1042. PubMed ID: 30956075
[TBL] [Abstract][Full Text] [Related]
16. Soft-tissue cryoablation in diffuse locations: feasibility and intermediate term outcomes.
Littrup PJ; Bang HJ; Currier BP; Goodrich DJ; Aoun HD; Heilbrun LK; Adam BA
J Vasc Interv Radiol; 2013 Dec; 24(12):1817-25. PubMed ID: 24060437
[TBL] [Abstract][Full Text] [Related]
17. Percutaneous CT- and MRI-guided Cryoablation of cT1 Renal Cell Carcinoma: Intermediate- to Long-term Outcomes in 307 Patients.
Bhagavatula SK; Tuncali K; Shyn PB; Levesque VM; Chang SL; Silverman SG
Radiology; 2020 Sep; 296(3):687-695. PubMed ID: 32633677
[TBL] [Abstract][Full Text] [Related]
18. Cost-effectiveness of minimally invasive partial nephrectomy and percutaneous cryoablation for cT1a renal cell carcinoma.
Wu X; Uhlig J; Shuch BM; Uhlig A; Kim HS
Eur Radiol; 2023 Mar; 33(3):1801-1811. PubMed ID: 36329348
[TBL] [Abstract][Full Text] [Related]
19. Tumor Growth Kinetics and Oncologic Outcomes of Patients Undergoing Active Surveillance for Residual Renal Tumor following Percutaneous Thermal Ablation.
Chen JX; Maass D; Guzzo TJ; Bruce Malkowicz S; Wein AJ; Soulen MC; Clark TWI; Nadolski GJ; William Stavropoulos S
J Vasc Interv Radiol; 2016 Sep; 27(9):1397-1406. PubMed ID: 27234485
[TBL] [Abstract][Full Text] [Related]
20. Percutaneous Cryoablation of Solitary, Sporadic Renal Cell Carcinoma: Outcome Analysis Based on Clear-Cell versus Papillary Subtypes.
Haddad MM; Schmit GD; Kurup AN; Schmitz JJ; Boorjian SA; Geske J; Thompson RH; Callstrom MR; Atwell TD
J Vasc Interv Radiol; 2018 Aug; 29(8):1122-1126. PubMed ID: 29887184
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
